Biotech

All Articles

Enanta's RSV antiviral crushes virus-like bunch in challenge study

.Enanta Pharmaceuticals has linked its own respiratory syncytial virus (RSV) antiviral to notable de...

Biogen canisters SAGE-324 cooperation after necessary shake stop working

.Biogen has actually administered the last ceremonies to its own partnership with Sage Rehabs on SAG...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel purchase credit ratings

.On the same day that some Parkinson's ailment medicines are being cast doubt on, AbbVie has actuall...

Arch closes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Project Allies is act...

Orion to make use of Aitia's 'electronic twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has spied potential in Aitia's "electronic identical twin" specialist to esta...

Windtree's surprise med rears high blood pressure in most recent stage 2 succeed

.While Windtree Therapies has strained to expand the economic origins required to survive, a stage 2...

2 cancer cells biotechs merge, making global footprint

.OncoC4 is taking AcroImmune-- as well as its own internal scientific production abilities-- under i...

Amgen files first phase 3 win for $400M eczema medication

.Amgen has actually shared (PDF) the very first period 3 records on its $400 million eczema medicati...

Biogen, UCB file phase 3 lupus succeed after stopping working earlier trial

.Biogen and UCB's rely on improving in to stage 3 astride an unsuccessful study aims to have repaid,...

Aptadir really hopes new RNA preventions can turn around tricky cancers

.Italian biotech Aptadir Rehabs has actually introduced with the assurance that its pipeline of prec...